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OVARIAN MALIGNANCY may result in the
accumulation of ascitic fluid in the peri-
toneal cavity. This fluid is similar in com-
position to serum and is in immediate con-
tact with the tumour. Dorsett et al. (1975)
show that this fluid contains tumour-
associated immunoglobulin. In the present
study, IgG was isolated from ascitic fluids
in an attempt to detect tumour antigen
in the patient's serum.
Five litres of ascitic fluid were obtained
by paracentesis from a 58-year-old female
patient with serous cystadenocarcinoma of
the ovary. The fluid was immediately cen-
trifuged 1000 g at 4°C, and stored at
-15TC. Ascitic fluid from 3 other female
patients at similar clinical stages of malig-
nancy (Stage III) was similarly treated.
IgG was separated from the ascitic fluid
by column chromatography, using QAE
Sephadex (Pharmacia, Sweden) ethylene
diamine acetate buffer at pH 7 0. ionic
strength 0 1 in a 41 column (120 cmX 7-0
cm) at 20TC (Joustra and Lunderen, 1969).
This was capable of separating in a single-
step procedure, the IgG fraction from 11
of ascitic fluid. The separation of the IgG
fraction was monitored visually, using
agar-gel electrophoretic plates (Corning
Ltd., California, U.S.A.). The electro-
phoresis was carried out using 10 al of the
column effluent at 20°C in 0 05 M barbitone
buffer, pH 8-6. The plates were stained
with 0-10% Coomassie blue in ethanol,
acetic acid and water (5:1:4) for 10 min
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and destained over 4 days in 10 changes of
0.85% NaCl. The final yield of IgG was
983 mg/l of fluid, as determined by the
Folin method (Lowry et al., 1951); this
was then concentrated to give 50 mg/ml of
protein. Confirmation that the isolated
ascitic-fluid protein was mainly IgG was
obtained when 10 ,ul (500 /tg protein) was
subjected to electrophoresis, using agar-
gel electrophoretic plates (Corning Ltd.,
California, U.S.A.) and anti-human sera
or anti-human IgG (20 ,ul) (Behringwerke,
Germany) was added to the side trough.
Diffusion was allowed to take place at 23°C
until precipitation arcs were visible, usu-
ally 16-18 h. The plates were stained and
destained as previously described in this
article.
Anallogeneic ovarium serous cystadeno-
carcinoma, a spontaneously aborted 16-
week-old foetus, and a normal allogeneic
ovary were homogenized separately in
phosphate-buffered saline (PBS) pH 7-2,
using a tissue homogenizer. The homo-
genates were then extracted with 1 0 M
perchloric acid (PCA) and centrifuged
4000 g at 4°C, and the supernatant was
freeze dried at 0-1 mmHg for 12 h. The
PCA extract was then reconstituted at 5
g/100 ml in 0-2 M PBS, pH 7-2. Ascitic
fluids (300 ml) from the 4 patients were
similarly treated with PCA. The super-
natant was concentrated using an Amicon
UM 10 (mol. wt retention limit 10,000)
filter (Amicon, Mass., U.S.A.) until the
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FIG. 1. Serum from cancer patients reacted
with the isolated ascitic-fluid y-globulin.
Upper wells contain IgG.
1. Serum from the cancer-patient donor
of the ascitic-fluid y-globulin.
2-4. Serum from 3 patients at the same
clinical stage of malignancy.
protein concentration reached 70 mg/ml
as determined by the Folin method.
The isolated IgG fraction gave a positive
reaction in the Ouchterlony (1958) diffu-
sion test against pooled normal human
serum. The reaction was probably due to
blood-group antigens and antibodies, so
the isolated IgG fraction was absorbed
against pooled normal human serum
(Avrameas and Ternynck, 1969). The suc-
cess of this treatment was determined by
the failure of the isolated IgG fraction to
give a positive reaction in the Ouchterlony
(1958) diffusion test against normal pooled
human serum. This method for assessing
antigen-antibody reactions was used
throughout the study. Plates were
prepared using Agarose (Biorad, Califor-
nia) 1 g/100 ml in 0 05 M barbitone
buffer, pH 8-6, and diffusion carried out
for 16-18 h at 230C. Staining and destain-
ing was carried out as previously described
in this article. To the plates, 10 pl (500 ,tg
protein) of the isolated IgG was allowed
to react with 10 pi of pooled normal
human serum, 10 pI (500 ,g protein) ex-
tracts of an allogeneic ovarian serous
cystadenocarcinoma, normal ovarian tis-
sue, 16-week-old foetus and 10 1l (700 ,tg
protein) PCA-treated and untreated auto-
logous and heterologous ascitic fluids.
The inhibitory effect ofthe isolated IgG
in a micro-radioimmunoassay for carcino-
embryonic antigen (CEA) was determined
(MacSweenetal., 1972). Briefly, themethod
employs double antibodyprecipitationand
the residual radioactivity is counted in the
supernatant. The limit ofsensitivity ofthe
assay is 3 ng/ml CEA. The concentration
of IgG used in the assay was 500 ,ug of
protein in 10 pl.
Serum and ascitic fluid from the patient
from whom the IgG was isolated, including
the isolated IgG, were tested for rheuma-
toid factor, using the Latex-RF-Reagenz
kit (Behringwerke A.G., West Germany).
The concentration of IgG used was 500 Hg
protein in 10 pl.
The purified ascitic-fluid IgG was re-
acted with the serum, ascitic fluid and
PCA extracts of ascitic fluid from the 4
cancer patients, as well as with the PCA
extracts of an allogeneic ovarian tumour,
a whole foetus and an allogeneic ovary.
Serum, ascitic fluid and a PCA extract
of ascitic fluid of the patient from whom
the IgG was isolated, reacted with this
tIG. 2.-PCIA extracts ofascitic fluid and ovarian tumour tissue reacted with the isolated ascitie-fluid
y-globulin. Right-hand wells contain IgG.
1. PCA extract of donor aseitic fluicd.
2. PCA extract of ovarian tumour tissue.
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TABLE.-Calibration curve for CEA with




Without IgG With IgG (colonic, ng)
22,634 22,650 50 ng
22,640 22,618
20,213 19,791 25 ng
19,836 21,010
17,614 17,302 12 ng
17,314 17,526
16,003 16,512 6 ng
16,471 15,819
15,211 15,020 3 ng
16,023 14,279
F (variance)=003 P>0-20
IgG (Figs. 1 and 2). The PCA extract of
the allogeneic ovarian serous cystadeno-
carcinoma also reacted with this IgG (Fig.
2). The serum, ascitic fluid and PCA ascitic
fluid extracts from the 3 other patients did
not react with the isolated IgG, neither did
the PCA extract of the whole foetus, nor
the PCA extract of the normal allogeneic
ovary.
In the radioimmunoassay for CEA, the
addition of the isolated IgG did not have
a significant inhibitory effect on the assay
(Table).
Rheumatoid-factor-like activity could
not be detected in the serum or ascitic
fluid of the patient from whom the IgG
was isolated. In addition, the isolated IgG
was shown not to have rheumatoid-factor
activity.
The reactivity of IgG with the patient's
serum and ascitic fluid, suggests that anti-
body or antibodies have been produced in
response to the tumour. This further sug-
gests that the antigen(s) responsible for
eliciting this humoral response is not a
normal phase-specific component, since
antibodies are not normally elicited by
such components to the extent that they
can be detected by immunodiffusion. In
addition, the IgG did not react with a
PCA extract of foetal tissue or inhibit the
radioimmunoassay for CEA. The IgG did
not react with a PCA extract of normal
allogeneic ovarian tissue, butdidreactwith
a PCA extract of an allogeneic serous
cystadenocarcinoma. Therefore, it is pos-
sible that the antigen(s) involved in elicit-
ing a humoral response in this patient is
tumour-specific. It may be shared by other
carcinomas, as in the case of ovarian cyst-
adenocarcinoma and squamous-cell carci-
noma of the cervix (Bhattacharya et al.,
1974). The failure ofthe IgG to react with
the serum or ascitic fluid from patients
with similar malignancies may be a reflec-
tion of the low levels of circulating anti-
gen(s) in these patients.
The use of xenogeneic antisera in the
detection of malignant neoplasms may
result in the detection of phase-specific
antigens which are present innormal tissue
in trace amounts. For example, carcino-
embryonic antigen (CEA) is present in
normal plasma (Chu et al., 1972) as well as
in colon and lung (Lo Gerfo and Herter,
1972). Other oncofoetal antigens have been
found (Takahashi et al., 1967; Buffe et al.,
1968; Hakkinen and Viikari, 1969; Purves
et al., 1970; Edynak et al., 1972; Banwo et
al., 1974) but none is tumour specific. The
identification of tumour-specific antigens
would obviously be of value in the diag-
nosis ofmalignant neoplasms.
This work was supported by the Australian Na-
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